Abstract
Targeted Myeloablative Radiation Using 131I-Apamistamab Prior to Allogeneic Hematopoietic Cell Transplant for Patients with R/R AML Results in Robust Engraftment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have